Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Stomach Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1Malignant Solid Tumour 1Intestinal Neoplasms 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Digestive System Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1

Interventions

Irinotecan 35,10-methylenetetrahydrofolic acid 2tislelizumab 1spartalizumab 1repotrectinib 1pralsetinib 1palbociclib 1encorafenib 1Pemetrexed 1Levoleucovorin 1Leucovorin 1KRN-330 1Immune Checkpoint Inhibitors 1Imatinib Mesylate 1Gemcitabine 1Flucytosine 1Everolimus 1Cisplatin 1Cetuximab 1Capecitabine 1Ascorbic Acid 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Digestive System Neoplasms × Levoleucovorin × Clear all
NCT01681472 2020-09-25

PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer

Isofol Medical AB

Phase 1/2 Completed
32 enrolled 52 charts
Gastrointestinal

Colonic Neoplasms, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡